Skip to main content

Table 2 HPV results of ICC and CIN2/3 specimens tested by heat extraction and the RealTime assay

From: Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study

 

ICC

CIN 2/3

 

n

Prevalence (95% CI)

n

Prevalence (95% CI)

Total tested

114

--

75

--

Total with valid resultsa

100

--

69

--

  Positive for any HPVb

93

--

65

--

  HPV-16 positive

48

51.6% (41.6–61.5)

36

55.4% (43.3–66.8)

  HPV-18 positive

23

24.7% (17.1–34.4)

5

7.7% (3.3–16.8)

  Other HR HPV positive

38

40.9% (31.4–51.0)

43

66.2% (54.0–76.5)

HPV-16 and/or HPV-18 positive

65

69.9% (59.9–78.3)

38

58.5% (46.3–69.6)

  1. aInvalid results mean the β-globin internal control was not reactive or had a Ct value of >35.
  2. bIncluding specimens with multiple HPV types identified. The number of specimens that were positive for HPV was used as the denominator for prevalence estimates.